Congenital non-communicating hydrocephalus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269510OMIM:236600Q03.1Q03.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital non-communicating hydrocephalus, also known as congenital obstructive hydrocephalus, is a condition present at birth in which cerebrospinal fluid (CSF) accumulates within the brain's ventricular system due to a physical blockage that prevents normal CSF flow between the ventricles or from the ventricles to the subarachnoid space. This distinguishes it from communicating hydrocephalus, where CSF can flow freely between ventricles but is inadequately absorbed. The obstruction may occur at various points, including the aqueduct of Sylvius (aqueductal stenosis, ICD-10 Q03.0 being a specific subtype), the foramina of Monro, or the outlets of the fourth ventricle. Causes include congenital malformations, prenatal infections, or developmental anomalies of brain structures. The condition primarily affects the central nervous system. As CSF accumulates, intracranial pressure rises, leading to enlargement of the ventricles and, in infants whose skull sutures have not yet fused, an abnormally rapid increase in head circumference (macrocephaly). Key clinical features include a bulging fontanelle, prominent scalp veins, irritability, poor feeding, vomiting, downward deviation of the eyes ("sunset sign"), and developmental delays. If left untreated, progressive hydrocephalus can cause significant brain damage, intellectual disability, seizures, and potentially life-threatening increases in intracranial pressure. Treatment is primarily surgical. The most common intervention is the placement of a ventriculoperitoneal (VP) shunt, which diverts excess CSF from the brain ventricles to the abdominal cavity where it can be absorbed. Endoscopic third ventriculostomy (ETV) is an alternative procedure that creates a new pathway for CSF drainage and may be preferred in certain cases of obstructive hydrocephalus. Early diagnosis and intervention are critical for optimizing neurodevelopmental outcomes. Long-term follow-up is essential, as shunt complications including malfunction, infection, and the need for revision surgeries are common. Prognosis varies widely depending on the underlying cause, severity, and timeliness of treatment.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital non-communicating hydrocephalus.

View clinical trials →

No actively recruiting trials found for Congenital non-communicating hydrocephalus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital non-communicating hydrocephalus community →

No specialists are currently listed for Congenital non-communicating hydrocephalus.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital non-communicating hydrocephalus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital non-communicating hydrocephalusForum →

No community posts yet. Be the first to share your experience with Congenital non-communicating hydrocephalus.

Start the conversation →

Latest news about Congenital non-communicating hydrocephalus

No recent news articles for Congenital non-communicating hydrocephalus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital non-communicating hydrocephalus

What is Congenital non-communicating hydrocephalus?

Congenital non-communicating hydrocephalus, also known as congenital obstructive hydrocephalus, is a condition present at birth in which cerebrospinal fluid (CSF) accumulates within the brain's ventricular system due to a physical blockage that prevents normal CSF flow between the ventricles or from the ventricles to the subarachnoid space. This distinguishes it from communicating hydrocephalus, where CSF can flow freely between ventricles but is inadequately absorbed. The obstruction may occur at various points, including the aqueduct of Sylvius (aqueductal stenosis, ICD-10 Q03.0 being a spec

At what age does Congenital non-communicating hydrocephalus typically begin?

Typical onset of Congenital non-communicating hydrocephalus is neonatal. Age of onset can vary across affected individuals.